AGO TUMOR - AN OVERVIEW

Molecular typing is based on molecular genetic testing and isn't however routinely out there. Molecular subtypes and immunohistochemical surrogate markers on the tumors (HR, HER2, triple negative) correlate in about 70%. The differentiation of luminal A and B subtypes by HR position and proliferation markers like Ki-67 could be valuable, but a poss